Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Other Accumulated Expenses: 2016-2024

Historic Other Accumulated Expenses for Adma Biologics (ADMA) over the last 7 years, with Dec 2024 value amounting to $2.0 million.

  • Adma Biologics' Other Accumulated Expenses fell 22.71% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 22.71%. This contributed to the annual value of $2.0 million for FY2024, which is 15.60% down from last year.
  • As of FY2024, Adma Biologics' Other Accumulated Expenses stood at $2.0 million, which was down 15.60% from $2.4 million recorded in FY2023.
  • In the past 5 years, Adma Biologics' Other Accumulated Expenses registered a high of $2.4 million during FY2023, and its lowest value of $207,262 during FY2020.
  • For the 3-year period, Adma Biologics' Other Accumulated Expenses averaged around $2.1 million, with its median value being $2.0 million (2024).
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 373.66% in 2021, then decreased by 15.60% in 2024.
  • Yearly analysis of 5 years shows Adma Biologics' Other Accumulated Expenses stood at $207,262 in 2020, then spiked by 373.66% to $981,721 in 2021, then soared by 82.94% to $1.8 million in 2022, then spiked by 31.68% to $2.4 million in 2023, then dropped by 15.60% to $2.0 million in 2024.